Cargando…

血液肿瘤双特异性抗体药物的临床研究进展

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440625/
https://www.ncbi.nlm.nih.gov/pubmed/37550197
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.05.015
_version_ 1785093200795402240
collection PubMed
description
format Online
Article
Text
id pubmed-10440625
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-104406252023-08-22 血液肿瘤双特异性抗体药物的临床研究进展 Zhonghua Xue Ye Xue Za Zhi 综述 Editorial office of Chinese Journal of Hematology 2023-05 /pmc/articles/PMC10440625/ /pubmed/37550197 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.05.015 Text en 2023年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License.
spellingShingle 综述
血液肿瘤双特异性抗体药物的临床研究进展
title 血液肿瘤双特异性抗体药物的临床研究进展
title_full 血液肿瘤双特异性抗体药物的临床研究进展
title_fullStr 血液肿瘤双特异性抗体药物的临床研究进展
title_full_unstemmed 血液肿瘤双特异性抗体药物的临床研究进展
title_short 血液肿瘤双特异性抗体药物的临床研究进展
title_sort 血液肿瘤双特异性抗体药物的临床研究进展
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440625/
https://www.ncbi.nlm.nih.gov/pubmed/37550197
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.05.015
work_keys_str_mv AT xuèyèzhǒngliúshuāngtèyìxìngkàngtǐyàowùdelínchuángyánjiūjìnzhǎn
AT xuèyèzhǒngliúshuāngtèyìxìngkàngtǐyàowùdelínchuángyánjiūjìnzhǎn
AT xuèyèzhǒngliúshuāngtèyìxìngkàngtǐyàowùdelínchuángyánjiūjìnzhǎn